Cases We Accept

Blog

Defective Products & Liability

View All

Latest News

View All

Library

Defective Products & Liability

View All

Case Results

$ 3.5 million Settlement for
auto injury

Our eighteen-year-old client was driving on an interstate into the early morning sun. As he drove over a rise in the road, he struck a car that was disabled and stopped in the middle of the road because a 150-pound wheel and tire detached from a tractor-trailer rig traveling in the opposite direction. The lugs holding the tire had broken off, causing the tire and wheel to travel across the median strip, and hit and disable the stopped vehicle.
Awarded: $ 3.5 million

$1,000,000 Jury Verdict for
86 year-old woman

Our client an 86 year-old woman sustained an injury after being struck by a bus. The inattentive bus driver was warned by a passenger that the woman was crossing in front of the bus but could not stop in time to avoid impact.
Awarded: $1,000,000

$785,000 Settlement for
crushed ankle

Our client was operating his motorcycle on a two-lane road when a large box truck made a U-turn into his path of travel. The client attempted to avoid the collision by laying his motorcycle on its side. Unfortunately his lower leg and ankle came in contact with the truck causing seven fractures and soft tissue injury.
Awarded: $785,000

DISCLAIMER: Please note that every case is different and these verdicts and settlements, while accurate, do not represent what we may obtain for you in your case.

Latest News

Massachusetts Attorney General Makes Deal with Bayer Over Yaz Ads

Posted on Feb 11, 2009

An agreement has been made with Bayer Corp. on Monday, February 9, 2009 with the Massachusetts Attorney General’s office, as well as 26 other states. The agreement had to do with allegations that Bayer’s 2008 marketing campaign of the birth control pill, Yaz, violated the terms of a 2007 agreement by not disclosing the uses the Food and Drug Administration had approved for Yaz.

According to Monday’s judgment, Bayer will be required to submit all television advertisements to the FDA for pre-approval and will be required to comply with all changes suggested by the FDA. Bayer will also have to disclose the uses of Yaz that have been approved by the FDA in any print advertisements. In addition to changing its advertisements, Bayer also has to perform a $20 million corrective advertising campaign to remedy misinformation from the Yaz advertisements.

The FDA had sent an earlier warning letter to Bayer, which addressed two misleading direct-to-consumer advertisements for Yaz. In one of the advertisements, Bayer promoted Yaz as a way to treat the symptoms of relatively common premenstrual syndrome (PMS) when the company had not been given an approval to treat this condition. The FDA letter also warned Bayer about overstating the effects Yaz had on acne.

“This is a great example of collaboration between the FDA and state Attorneys General. By working together, we can achieve excellent results and double our efforts to clean up misleading advertising in the marketplace. This significantly benefits the public by ensuring that consumers are not misled about information relating to their health,” said Tom Abrams, director of the FDA’s Division of Drug Marketing, Advertising, and Communications.

Share |

Need Help Now?

Kiley Law Group
342 North Main Street
P.O. Box 3040
Andover, MA 01810
Phone: 978-474-8670
Fax: 978.474.8946
Toll Free: 800-410-2769

Get Directions